Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mometasone - Intersect ENT

Next Previous
X
Search
Drug Profile

Mometasone - Intersect ENT

Alternative Names: ASCEND mometasone furoate-coated sinus balloon; Bioabsorbable mometasone-eluting sinus implants - Intersect ENT; Controlled-release-mometasone-furoate; mometasone controlled-release implant - Intersect ENT; Mometasone furoate - Intersect; Mometasone furoate implant; Mometasone-eluting stent; Mometasone-releasing S8 sinus implant - Intersect ENT; NOVA sinus implant; PROPEL; PROPEL Contour; PROPEL mini; RESOLVE®; SINUVA; Steroid-releasing sinus implant

Latest Information Update: 18 Oct 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Intersect ENT
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated hydrocarbons; Furans; Glucocorticoids; Phenanthrenes; Pregnadienediols; Skin disorder therapies; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Sinusitis

Most Recent Events

  • 20 May 2021 Adverse events data from the phase IV PROGRESS trial for Sinusitis released by Intersect ENT
  • 23 Jun 2020 Launched for Sinusitis in United Kingdom (Intranasal) before June 2020
  • 22 Jun 2020 Registered for Sinusitis in United Kingdom (Intranasal) before June 2020

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top